Infusional chemotherapy combined with recombinant human granulocyte colony stimulating factor advantages and limitations

We have studied the simultaneous administration of granulocyte colony stimulating factor (G-CSF), given concomitantly with an infusion of either doxorubicin or ifosphamide--the former, both intraarterially (i.a.) and intravenously (i.v.), the latter, intravenously--to a group of patients with variou...

Ausführliche Beschreibung